Dr. Tatiana Khrom is excited to announce a breakthrough addition, the FDA Approved Winlevi for Acne Treatment, to her Brooklyn NY practice. Winlevi is the first acne medication with a new “mechanism of action,” to get the stamp of approval from the FDA in almost four decades; the last such drug, Accutane, is one of the most powerful oral acne medications on the market. A topical cream, Winlevi uses a new active ingredient, 1% clascoterone, to target the androgen receptors that promote sebum (oil) buildup and inflammation. Like birth control pills that moderate acne among women, Winlevi is an “anti-androgen.” In topical form, Winlevi avoids systemic effects and may be prescribed to men as well as women. Winlevi may be combined with other topicals and antibiotics to treat severe acne.